Nicotinamide Riboside (NR): What the Evidence Actually Says About This NAD⁺ Booster
Nicotinamide Riboside (NR): What the Evidence Actually Says About This NAD⁺ Booster
In 2004, biochemist Charles Brenner was studying a mysterious nutrient in milk when he made a discovery that would launch a supplement empire: a form of vitamin B3 the body can turn directly into NAD⁺ — the molecule that powers every cell and declines sharply with age. He called it nicotinamide riboside, licensed it to a company called ChromaDex, and watched it become one of the best-selling "anti-aging" supplements on Earth under the brand name Niagen. Twenty years later, the science has delivered a humbling verdict: nicotinamide riboside reliably raises NAD⁺ in human blood — often dramatically — but translating that into a longer, healthier life has proven far harder than the marketing suggested.
Evidence Tier: 🥈 Silver — more human randomized controlled trials than almost any other NAD⁺ precursor, consistently showing it safely raises NAD⁺ levels; but the functional benefits (muscle, metabolism, cognition) are inconsistent and often absent, and most trials were funded by the company that sells it.
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: Reliably and dose-dependently raises NAD⁺ in human blood — the one finding every trial agrees on, with increases of roughly 40–100% at common doses.
- Excellent safety record: Tested up to 2,000 mg/day with no serious side effects across multiple randomized trials in hundreds of people.
- Regulatory clarity: NR (Niagen) has FDA New Dietary Ingredient and GRAS notification, so it remains a legal supplement — unlike NMN, which was pulled from the US market in 2022.
- Emerging disease signals: Small trials hint at benefit in Parkinson's disease, age-related muscle repair, and mild cognitive impairment — worth watching.
❌ Cons (What the Evidence Doesn't Support or Warns About)
- Biggest limitation: Raising NAD⁺ in blood has not translated into consistent improvements in muscle function, metabolism, or physical performance in healthy people.
- Funding bias: The vast majority of human NR trials were funded by ChromaDex (maker of Niagen), and its discoverer is a company advisor — a real conflict to weigh.
- No longevity proof: Zero human studies show NR extends lifespan or healthspan; the anti-aging claim rests entirely on the NAD⁺-declines-with-age theory.
- Unknown long-term safety: No human trial has run longer than about 12 weeks, and a theoretical concern exists that NAD⁺ precursors could fuel cancer cells.
📋 Simple Summary
Nicotinamide riboside (NR) is a form of vitamin B3 — the same vitamin family as niacin — that your body converts into NAD⁺, a molecule found in every cell that helps turn food into energy and repairs DNA. NAD⁺ levels drop by roughly half as you get older, and many researchers believe that decline drives the aging process. NR pills raise NAD⁺ in your blood reliably and safely, and that's the good news. The bad news: in study after study, raising NAD⁺ with NR has mostly not improved muscle strength, endurance, or metabolism in healthy people. A few early trials hint it might help in specific situations — Parkinson's disease, muscle repair after injury, early memory problems — but those are small and preliminary. Our verdict: NR is a safe, well-studied way to raise NAD⁺, and it's worth a careful look if NAD⁺ is your goal — but don't expect it to make you feel younger or live longer, because the evidence for that just isn't there yet.
What Is Nicotinamide Riboside?
Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3, found in trace amounts in milk, yeast, and some other foods. The vitamin B3 family is actually a group of related molecules — nicotinic acid (niacin), nicotinamide (niacinamide), nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) — and they all share one job: they are building blocks for NAD⁺ (nicotinamide adenine dinucleotide), a coenzyme that every living cell needs to survive.
What makes NR special is the route it takes into cells. It was discovered in 2004 by Charles Brenner, a biochemist then at Dartmouth, who showed that NR enters cells through a dedicated enzyme called NR kinase and converts to NAD⁺ more directly than niacin or nicotinamide. In 2016 it was formally recognized as a vitamin for the first time in decades. The company ChromaDex commercialized a specific, patented form called nicotinamide riboside chloride, sold under the brand Niagen (and in consumer products as Tru Niagen). When studies refer to "NR," they almost always mean Niagen.
How It Works
To understand NR, you first have to understand NAD⁺. Think of NAD⁺ as the cell's universal battery — it shuttles electrons during metabolism, helping mitochondria (the cell's power plants) turn food into usable energy. NAD⁺ is also a fuel for three families of proteins that matter enormously for aging:
- Sirtuins — "longevity proteins" that switch on DNA repair and stress resistance; they need NAD⁺ to work.
- PARPs — enzymes that repair damaged DNA; they consume NAD⁺ to fix breaks.
- CD38 — an enzyme that destroys NAD⁺, and whose activity rises with age (one reason NAD⁺ falls).
NAD⁺ levels decline roughly 50% between young adulthood and old age, and this decline correlates with many hallmarks of aging: failing mitochondria, accumulated DNA damage, and chronic inflammation. The theory behind NR (and NMN) is simple: if you supply more raw material, the body makes more NAD⁺, sirtuins and PARPs work better, and cells stay healthier longer.
In practice, the first half of that theory holds up beautifully — NR does raise NAD⁺ in human blood, muscle, and even brain. The second half — that more NAD⁺ actually improves function — is where the human evidence gets shaky, as the studies below show.
The Longevity Connection
Here is what the human evidence actually supports, ranked by strength.
🥇 NAD⁺ restoration (strong, consistent): This is the one rock-solid finding. In the landmark 2018 Martens trial, 1,000 mg/day for 6 weeks raised blood NAD⁺ in healthy 55–79-year-olds by roughly 60%. The 2019 Conze trial showed the effect is dose-dependent — NAD⁺ rose more at 1,000 mg than at 300 mg than at 100 mg — across 140 people. NR's ability to raise NAD⁺ is not in dispute.
🥇 Safety (strong, consistent): Across every randomized trial — including 2,000 mg/day for 12 weeks — NR has produced no serious adverse events and only mild, infrequent side effects like nausea or headache. On safety, the record is genuinely reassuring.
🥉 Muscle and metabolic function (weak, mostly null): Here the story falls apart. The 2019 Elhassan trial raised muscle NAD⁺ in older men but found no improvement in muscle mitochondrial function or strength. The 2020 Dollerup trial found no change in mitochondrial respiration in obese men. A 2020 Remie trial found only a tiny increase in fat-free mass and a shift in how muscle burns fuel. The 2023 twin study found no change in muscle performance at all. Raising NAD⁺, it turns out, is not the same as fixing muscle.
🥈 Brain health and neurodegeneration (emerging, promising): The 2022 NADPARK trial in 30 people with early Parkinson's found NR raised brain NAD⁺ and reduced inflammatory markers, with a modest signal of motor improvement. Two small trials in people with mild cognitive impairment (2024 and 2026) showed NR safely raised NAD⁺ and hinted at cognitive benefit, but were too small to be conclusive. This is the most exciting area for NR right now.
🥈 Muscle repair in aging (emerging): A 2022 trial in 32 older adults found that NR combined with pterostilbene improved muscle regeneration after injury — one of the few genuinely positive functional results. Note it was a combination, not NR alone.
🥈 Blood pressure (emerging): A 2025 pilot trial in 54 adults with elevated blood pressure suggested NR combined with exercise may help lower blood pressure more than exercise alone — early and unconfirmed.
⚠️ Human lifespan extension (not shown): No human study has demonstrated that NR extends lifespan or healthspan. In animal models, NR has extended lifespan in some (but not all) studies, and human lifespan data simply does not exist. Anyone selling NR as a proven longevity pill is overstating the evidence.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Martens et al., 2018 (PMID 29599478) | 6 weeks, 1,000 mg/day, 24 healthy adults aged 55–79 | Raised blood NAD⁺ by ~60%; well tolerated. The study that launched the NR craze. |
| Conze et al., 2019 (PMID 31278280) | 8 weeks, 100/300/1,000 mg/day, 140 overweight adults | Dose-dependent NAD⁺ increase; no serious side effects; no liver enzyme changes. |
| Elhassan et al., 2019 (PMID 31412242) | 21 days, 1,000 mg/day, 12 older men | Raised muscle NAD⁺ and reduced inflammatory markers, but no change in muscle function. |
| Dollerup et al., 2020 (PMID 31710095) | 12 weeks, 1,000 mg/day, obese insulin-resistant men | No change in mitochondrial respiration or muscle content — a key negative result. |
| Remie et al., 2020 (PMID 32320006) | 6 weeks, 1,000 mg/day, 13 overweight/obese adults | Small increase in fat-free mass and a shift toward fat oxidation, but no insulin sensitivity change. |
| Jensen et al., 2022 (PMID 35998039) | NR + pterostilbene (NRPT), 32 adults aged 55–80, muscle injury model | Improved muscle regeneration after injury — one of the few clear functional wins. |
| Brakedal et al., 2022 — NADPARK (PMID 35235774) | 30 days, 1,000 mg/day, 30 people with early Parkinson's | Raised brain NAD⁺ and reduced neuroinflammation markers; modest motor signal. |
| Lapatto et al., 2023 (PMID 36638183) | 5 weeks, 1,000 mg/day, 20 identical twins | No muscle performance benefit; shifted the gut microbiome composition. |
| Orr et al., 2024 (PMID 37994989) | 10 weeks, 1 g/day, 20 older adults with mild cognitive impairment | Safely raised NAD⁺; no significant cognitive change in this small pilot. |
| NR + exercise pilot, 2025 (PMID 40770531) | 6 weeks, 1,000 mg/day + walking, 54 adults with elevated blood pressure | NR + exercise trended toward better blood-pressure reduction than exercise alone. |
Dosing and Safety
How to take it: Most of the human evidence sits at 1,000 mg/day, and that's the dose most longevity-focused people choose. There's no strong evidence that higher doses help more for functional outcomes, and the NAD⁺-raising effect largely plateaus, so more isn't necessarily better. Take it in the morning — a minority of users report mild energy or alertness after taking it, and it's simple to pair with breakfast.
| Goal | Typical Dose | Notes |
|---|---|---|
| General NAD⁺ support | 300–1,000 mg/day | The sweet spot; 300 mg is a reasonable starting dose, 1,000 mg is the most-studied. |
| Highest studied dose | 2,000 mg/day (split) | Tested safe for 12 weeks, but no clear benefit over 1,000 mg. |
| Disease-specific (investigational) | 1,000 mg/day | The dose used in the Parkinson's, MCI, and hypertension pilot trials. |
Form: Almost all the research used nicotinamide riboside chloride — the patented form sold as Niagen (ChromaDex). This is the form to look for on a label if you want the version that's actually been studied. Avoid "NR" products that don't specify Niagen or the chloride form, since the market is full of unverified generics. Note that NR is not the same as niacin, and it does not cause the uncomfortable "niacin flush" that makes many people avoid regular B3.
Side effects: NR is remarkably well tolerated. Across trials, side effects were mild and uncommon — occasionally nausea, headache, indigestion, fatigue, or mild flushing — and they usually resolved on their own. No serious adverse events have been reported in human trials, and no liver enzyme elevations were seen even at high doses.
The two caveats that matter:
- Cancer caution (theoretical): Because NAD⁺ fuels cell metabolism, some researchers worry that NAD⁺ precursors could also fuel the growth of existing cancer cells. This is biologically plausible but unproven in humans — there is no clinical evidence that NR causes or accelerates cancer. Still, if you have active cancer or are undergoing treatment, this is a real reason to talk to an oncologist first.
- Industry funding (real): ChromaDex, the company that sells Niagen, funded most of the human NR trials, and its discoverer Charles Brenner is a long-time company advisor. This doesn't invalidate the data, but it means the published record leans optimistic, and the negative findings (which came largely from independent academic groups) are worth extra weight.
❓ Common Questions About Nicotinamide Riboside
What is nicotinamide riboside and how does it work?
Nicotinamide riboside (NR) is a form of vitamin B3 that your body turns into NAD⁺, a molecule every cell needs to make energy and repair DNA. NAD⁺ levels fall by about half as you age, so the idea is that taking NR restocks that supply. It reliably raises NAD⁺ in the blood — that part is well proven.
What does the evidence actually show?
The evidence is clear that NR safely and consistently raises NAD⁺ levels in people, with a strong safety record across many trials. But it is also clear that this doesn't reliably improve muscle strength, endurance, or metabolism in healthy people — most of those trials came back negative. A few small studies hint at benefits for Parkinson's disease, muscle repair, and early memory problems, but they're too early to count as proof.
What's the right dose?
The most-studied dose is 1,000 mg per day, and that's what most longevity-focused people take, usually in the morning. Starting lower (around 300 mg) is fine and lets you see how you respond. Doses up to 2,000 mg a day have been tested safely for 12 weeks, but there's no clear benefit to going above 1,000 mg.
What are the risks and side effects?
NR is very well tolerated — side effects are mild and uncommon, mainly occasional nausea, headache, or indigestion, and no serious side effects have been reported in human trials. The main uncertainties are long-term (no trial has run much past 12 weeks) and a theoretical concern that NAD⁺ precursors could fuel existing cancer cells. Unlike niacin, NR does not cause the skin flush.
Who should avoid it?
Pregnant or breastfeeding women should avoid it, since there's no safety data for them. Anyone with active cancer or undergoing cancer treatment should talk to their oncologist first, because of the theoretical concern that NAD⁺ precursors could fuel tumor growth. And anyone on prescription medication should check with their doctor before adding any supplement.
The Bottom Line
Where the evidence ranks: Nicotinamide riboside is the most heavily studied NAD⁺ precursor on the market, and it does exactly one thing with certainty: it raises NAD⁺. That's a real, measurable, reproducible effect. What it has not done is deliver the downstream benefits the theory predicts — stronger muscles, better metabolism, slower aging — in healthy people. The honest read of the literature is that NR is a safe, effective NAD⁺ booster whose health benefits remain largely unproven, with the most interesting (and still preliminary) signals appearing in specific disease contexts like Parkinson's and muscle repair.
Our verdict: If your goal is specifically to raise NAD⁺ — and you accept that this may not translate into feeling or aging differently — NR is a defensible, well-studied choice, and arguably a better-documented one than NMN (which is also harder to buy legally in the US). If your goal is concrete longevity benefit, temper your expectations: nothing has yet shown NR extends human life or healthspan. The free interventions (sleep, exercise, not smoking, keeping blood sugar and blood pressure in check) still move the needle far more than any NAD⁺ pill.
Who it's for: Evidence-minded people who want to maintain NAD⁺ levels as they age, understand the limits of the science, and are comfortable paying for a well-tested branded form (Niagen). It's not for anyone expecting a dramatic, feel-it-tomorrow effect, and it's not for anyone with active cancer without an oncologist's sign-off.
Medical Disclaimer: This page is for educational purposes only and is not medical advice. Nicotinamide riboside is a supplement, not a treatment for any disease, and it can interact with medications and may be inappropriate for people with certain conditions, including cancer. Always consult a qualified healthcare professional before starting any supplement.
Sources
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults. Nature Communications. 2018. PMID 29599478
- Conze D, et al. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. 2019. PMID 31278280
- Elhassan YS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD⁺ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. 2019. PMID 31412242
- Dollerup OL, et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. The Journal of Physiology. 2020. PMID 31710095
- Dollerup OL, et al. Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity. The Journal of Clinical Endocrinology & Metabolism. 2019. PMID 31390002
- Remie CME, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. The American Journal of Clinical Nutrition. 2020. PMID 32320006
- Lapatto HAK, et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Science Advances. 2023. PMID 36638183
- Jensen JB, et al. A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals. JCI Insight. 2022. PMID 35998039
- Brakedal B, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 2022. PMID 35235774
- Orr ME, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024. PMID 37994989
- Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial. GeroScience. 2025. PMID 40770531
- A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. Alzheimer's & Dementia. 2026. PMID 42478598
- Conze DB, et al. Safety assessment of nicotinamide riboside, a form of vitamin B3. Human & Experimental Toxicology. 2016. PMID 26791540
- Dietary Supplementation With NAD⁺-Boosting Compounds in Humans: Current Knowledge and Future Directions. The Journals of Gerontology: Series A. 2023. PMID 37068054
- NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. Molecular Biology Reports. 2026. PMID 42489969